Invivyd Reports First Quarter 2026 Financial Results and Recent Business Highlights

Achieved Q1 2026 PEMGARDA® (pemivibart) net product revenue of $13.7 million, representing 22% growth versus Q1 2025 net product revenue of $11.3 ...
Pulmonology Advisor

GINA 2026 Update: Asthma Management in Primary Care, Biologic Updates, and More

The GINA 2026 update covers primary care management of asthma exacerbations, fatality risk factors, biologic selection, and ...

Verrica Pharmaceuticals Inc.: Verrica Pharmaceuticals Reports First Quarter 2026 Financial Results

Company reports record demand for YCANTH as dispensed applicator units grew to 15,302 in Q1 2026, up 12.1% over the previous quarter and 51.3% year-over-year, and has now exceeded 100,000 dispensed ...

Genovis AB: Genovis and MGI Tech Strengthen Collaboration to Advance RNA Sequencing Solutions

Genovis AB and MGI Tech Co., Ltd. today announce a strengthened collaboration to advance RNA sequencing solutions. The companies have expanded their commercial agreement to integrate Genovis' SEQURNA ...
Everyday Health on MSN

44 gifts to make life easier for people with autoimmune symptoms

These autoimmune gift ideas were tested by Everyday Health writers and informed by experts. Shop sleep aids, snacks, skin ...